Bulletin
Investor Alert

press release

March 17, 2022, 8:05 a.m. EDT

BioLife Solutions Announces Additional Delay in Filing of Annual Report on Form 10-K

BOTHELL, Wash., March 17, 2022 /PRNewswire/ --  BioLife Solutions, Inc. /zigman2/quotes/207858501/composite BLFS +0.61%  ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies (CGT) and the broader biopharma markets, announced today an additional delay in the filing of its Annual Report on Form 10-K for the year ended December 31, 2021 (the "Form 10-K").

Troy Wichterman, Chief Financial Officer, stated, "We are working diligently to complete our Form 10-K and intend to file the Form 10-K no later than March 31, 2022".

About BioLife Solutions

BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. Our tools portfolio includes our proprietary  CryoStor ® and HypoThermosol®  biopreservation media for shipping and storage, the ThawSTAR ® family of automated, water-free thawing products,  evo ® cold chain management system,  high capacity cryogenic storage freezersStirling Ultracold  mechanical freezers,  SciSafe  biologic storage services, and Sexton Biotechnologies cell processing tools.  For more information, please visit www.biolifesolutions.com , www.scisafe.com , www.stirlingultracold.com , or www.sextonbio.com  and follow BioLife on Twitter .

Cautions Regarding Forward Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements concerning the Company's intention to file its Form 10-K no later than March 31, 2022 and other statements about the Company's plans, objectives, expectations, beliefs and intentions and other statements including words such as "hope," "anticipate," "may," "believe," "expect," "intend," "will," "should," "plan," "estimate," "predict," "continue" and "potential" or the negative of these terms or other comparable terminology. The forward-looking statements herein represent the judgment of the Company, as of the date of this release, and the Company disclaims any intent or obligation to update forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those currently anticipated. This press release should be read in conjunction with the information included in the Company's other press releases, reports and other filings with the SEC and on the SEC website, www.sec.gov . Understanding the information contained in these filings is important in order to fully understand the Company's reported financial results and our business outlook for future periods. Actual results may differ materially from the results anticipated in the forward-looking statements and the assumptions and estimates used as a basis for the forward-looking statements.

Media & Investor Relations 

At the Company

Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com  

Investors

LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com

Cision
View original content to download multimedia: https://www.prnewswire.com/news-releases/biolife-solutions-announces-additional-delay-in-filing-of-annual-report-on-form-10-k-301504834.html

SOURCE BioLife Solutions, Inc.

COMTEX_404296250/2454/2022-03-17T08:05:07

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright (C) 2022 PR Newswire. All rights reserved

/zigman2/quotes/207858501/composite
US : U.S.: Nasdaq
$ 21.49
+0.13 +0.61%
Volume: 396,806
Aug. 5, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$911.38 million
Rev. per Employee
$317,000
loading...

Comtex

Partner Center

Link to MarketWatch's Slice.